De Novo Design
Evaluation of model-designed nanobodies
Candidate statistics
| Protein name | Target | Subset | Design workflow | SEC purity (%) | SDS purity (%) | Single-point BLI net response | Nonspecific binding signal BVP ELISA measures nonspecific antibody binding to baculovirus particles. The reported value is a background-corrected net signal. Under matching assay and normalization conditions, lower values generally indicate less nonspecific binding. The assay helps assess polyreactivity and the risk of rapid clearance in vivo.Assay reference |
|---|---|---|---|---|---|---|---|
| RFantibody-IL7RA-060 | IL-7Rα | Ab002 | RFantibody × SolubleMPNN | Aggregation | -0.0014 | ||
| PPIFlow-IL7RA-001 | IL-7Rα | Ab002 | PPIFlow × AntiBMPNN | 11.9 | 98.4 | 0.0071 | |
| PPIFlow-IL7RA-002 | IL-7Rα | Ab002 | PPIFlow × AntiBMPNN | 30.2 | 100 | 0.0045 | |
| PPIFlow-IL7RA-003 | IL-7Rα | Ab002 | PPIFlow × AntiBMPNN | 98.2 | 98 | -0.0026 | |
| PPIFlow-IL7RA-004 | IL-7Rα | Ab002 | PPIFlow × AntiBMPNN | 95.2 | 98.7 | 0.0096 | |
| PPIFlow-IL7RA-005 | IL-7Rα | Ab002 | PPIFlow × AntiBMPNN | 98.4 | 96.2 | 0.0125 | |
| PPIFlow-IL7RA-006 | IL-7Rα | Ab002 | PPIFlow × AntiBMPNN | 68.8 | 91.6 | 0.0066 | |
| PPIFlow-IL7RA-007 | IL-7Rα | Ab002 | PPIFlow × AntiBMPNN | 90.6 | 97.6 | 0.0111 | |
| PPIFlow-IL7RA-008 | IL-7Rα | Ab002 | PPIFlow × AntiBMPNN | 79.7 | 88.4 | -0.0027 | |
| PPIFlow-IL7RA-009 | IL-7Rα | Ab002 | PPIFlow × AntiBMPNN | 81.1 | 95.4 | 0.0034 | |
| PPIFlow-IL7RA-010 | IL-7Rα | Ab002 | PPIFlow × AntiBMPNN | 93.6 | 96.1 | -0.0105 | |
| PPIFlow-IL7RA-011 | IL-7Rα | Ab002 | PPIFlow × AntiBMPNN | 93.4 | 97.1 | -0.0008 | |
| PPIFlow-IL7RA-012 | IL-7Rα | Ab002 | PPIFlow × AntiBMPNN | 88.5 | 99 | -0.0022 | |
| PPIFlow-IL7RA-013 | IL-7Rα | Ab002 | PPIFlow × AntiBMPNN | 82.8 | 97.9 | 0.0102 | |
| PPIFlow-IL7RA-014 | IL-7Rα | Ab002 | PPIFlow × AntiBMPNN | 58.5 | 98.6 | -0.0044 | |
| PPIFlow-IL7RA-015 | IL-7Rα | Ab002 | PPIFlow × AntiBMPNN | 94.5 | 98.3 | -0.0007 | |
| PPIFlow-IL7RA-016 | IL-7Rα | Ab002 | PPIFlow × AntiBMPNN | 82.2 | 98.3 | 0.0019 | |
| PPIFlow-IL7RA-017 | IL-7Rα | Ab002 | PPIFlow × AntiBMPNN | 4 | 89.0 9.6 | 0.0081 | |
| PPIFlow-IL7RA-018 | IL-7Rα | Ab002 | PPIFlow × AntiBMPNN | 93.5 | 95 | 0.0005 | |
| PPIFlow-IL7RA-019 | IL-7Rα | Ab002 | PPIFlow × AntiBMPNN | 88.4 | 98.4 | 0.0184 | |
| PPIFlow-IL7RA-020 | IL-7Rα | Ab002 | PPIFlow × AntiBMPNN | 90 | 99.1 | 0.0068 | |
| PPIFlow-IL7RA-021 | IL-7Rα | Ab002 | PPIFlow × ProteinMPNN | Low concentration; abnormal peak | -0.0031 | ||
| PPIFlow-IL7RA-022 | IL-7Rα | Ab002 | PPIFlow × ProteinMPNN | 84 | 96.9 | -0.0012 | |
| PPIFlow-IL7RA-023 | IL-7Rα | Ab002 | PPIFlow × ProteinMPNN | 77.2 | 98.8 | 0.0063 | |
| PPIFlow-IL7RA-024 | IL-7Rα | Ab002 | PPIFlow × ProteinMPNN | 93.3 | 98.6 | -0.006 |
226–250 of 286 candidates